<DOC>
	<DOC>NCT02823236</DOC>
	<brief_summary>The aim of the study is to assess the efficacy and safety of the combination of intralesional triamcinolone (at doses of 4mg / cm2 at intervals of 4 weeks) and topical pirfenidone 8% (every 8 hours continuously) compared with their isolated application, in the treatment of keloid scars in adults. The duration of this three-arm clinical trial will be 12 months, a 6-month period for treatment and a follow-up of 6 months to assess recurrences. The estimated number of persons to be recruited and randomized for the study is 102.</brief_summary>
	<brief_title>Efficacy of Intralesional Triamcinolone and 8% Topical Pirfenidone for Treatment of Keloid Scars</brief_title>
	<detailed_description>Individuals with keloid scars will be randomized to 3 arms of treatment in order to assess the efficacy of combining intralesional triamcinolone and topical pirfenidone compared with the isolated application of these drugs. The interventions will last 6 months but the individuals will be assessed monthly to determine recurrences for 6 more months. The scar size will be measure at weeks 12, 24 and 52.</detailed_description>
	<mesh_term>Keloid</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Pirfenidone</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>Keloids size equal or major than 1 cm Keloids less than 5 years old Keloids in trunk Keloid with a surgical indication Hypertrophic scars Scars after burn wounds Pregnancy Lactation Use of systemic chemotherapeutics or chronic use of systemic corticosteroids or immunosuppressive medication Known hypersensitivity for triamcinolone or pirfenidone Severe comorbidity not controlled Inflammatory acne Diabetes Mellitus Hypertension Renal, hepatic or respiratory failure Topical treatment 4 weeks before recruitment Previous treatment with intralesional steroids</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Keloid</keyword>
	<keyword>Scar</keyword>
</DOC>